204634-01-5
204634-01-5
Chemical Structure
Inosine-15N4
- CAS No.: 204634-01-5
- Formula:C10H1215N4O5
- Molecular Weight:272.20
IUPAC Name: (3R)-2-amino-1-(5-amino-2-methylphenyl)-3-(naphthalen-1-yl)butan-1-one
InChIKey: UGQMRVRMYYASKQ-SHKQESLVSA-N
SMILES: O[C@H]1[C@](O[C@@H]([C@H]1O)CO)([H])[15N]2C3=C(C([15N]=C[15NH]3)=O)[15N]=C2
Biological Activity: Inosine-15N4 is the 15N labeled Inosine[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Inosine-15N4 | 98.40% | Inosine-15N4 is the 15N labeled Inosine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine (Standard) | 99.93% | Inosine (Standard) is the analytical standard of Inosine. This product is intended for research and analytical applications. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors. In Vitro:Inosine dose-dependently stimulates cAMP production mediated through the A2AR. Inosine dose-dependently induces hA2AR-mediated ERK1/2 phosphorylation. Inosine (100 μM; 24 hours) reduces oxidative stress in MES 23.5 cells cultured with astrocytes. In Vivo:Inosine (10-100 mg/kg; i.p.) exhibits antinociceptive effect in mice. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine-13C5 | 99.90% | Inosine-13C5 is the 13C5 labeled Inosine (HY-N0092). Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine-13C3 | Inosine-13C3 is a 13C-labeled Inosine that can be used in pharmacokinetic studies of Inosine. Inosine is an agonist of adenosine receptors A1R and A2AR with anti-inflammatory immunomodulatory, antinociceptive and neuroprotective effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine-2,8-d2 | 99.69% | Inosine-2,8-d2 is the deuterium labeled Inosine. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine-13C | Inosine-13C is the 13C labeled Inosine. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Inosine | 99.94% | Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
